Rutgers study: Expanded use of a personalized remote risk communication intervention increased uptake of genetic counseling

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Genetic counseling and genetic testing for mutations in certain genes—e.g., BRCA1 and BRCA2—can help people understand their risk of certain types of cancer that can run in families, and improve outcomes through prevention, early detection, and targeted treatments, a study conducted at Rutgers Cancer Institutes found.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

For over 50 years, scientists have been on a quest to identify which malignant mutations within the tumor allow rogue cells to break away from the primary tumor and travel through the bloodstream and lymphatic system to metastasize throughout the body. Now, new research suggests an alternative mechanism has been overlooked—elusive mutations driving metastasis may not be developing within the twisted DNA of tumors themselves, but within the patient’s regular, inherited DNA. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login